Floatz logo

Fludarabine

Fanconi Anemia

Porteus, Matthew, MDSmall moleculePhase 2/3Active
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
67/ 100
Competitive Position
95/ 100

Competitive context

15 Active assets in the Fanconi Anemia cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Porteus, Matthew, MD
Phase 2/3BBB
FILGRASTIM
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2BBB
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 2BBB
Busulphan
Masonic Cancer Center, University of Minnesota
Phase 2/3BBB
PREDNISONE TABLETS
Fred Hutchinson Cancer Center
Phase 2BB

View all 44 →

Same molecule, other indications

Fludarabine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Adult Diffuse Large Cell LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
T-cell large granular lymphocyte leukemiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →